Cantel Medical Corp. (CMD) Shares Sold by Gamco Investors INC. ET AL
Gamco Investors INC. ET AL lowered its stake in shares of Cantel Medical Corp. (NYSE:CMD) by 13.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 82,630 shares of the company’s stock after selling 13,000 shares during the period. Gamco Investors INC. ET AL owned 0.20% of Cantel Medical Corp. worth $7,781,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of CMD. Globeflex Capital L P bought a new position in Cantel Medical Corp. in the 2nd quarter worth approximately $114,000. Integrated Investment Consultants LLC bought a new position in Cantel Medical Corp. in the 2nd quarter worth approximately $161,000. LS Investment Advisors LLC bought a new position in Cantel Medical Corp. in the 2nd quarter worth approximately $172,000. Airain ltd bought a new position in Cantel Medical Corp. in the 2nd quarter worth approximately $201,000. Finally, Punch & Associates Investment Management Inc. bought a new position in Cantel Medical Corp. in the 2nd quarter worth approximately $212,000. Institutional investors own 85.38% of the company’s stock.
Cantel Medical Corp. (NYSE:CMD) opened at $98.28 on Friday. The company has a market cap of $4,100.93, a P/E ratio of 47.25 and a beta of 1.23. Cantel Medical Corp. has a fifty-two week low of $69.21 and a fifty-two week high of $99.83. The company has a quick ratio of 1.49, a current ratio of 2.41 and a debt-to-equity ratio of 0.24.
Cantel Medical Corp. (NYSE:CMD) last released its quarterly earnings data on Thursday, September 28th. The company reported $0.54 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.02. Cantel Medical Corp. had a net margin of 9.27% and a return on equity of 17.60%. The company had revenue of $205.50 million during the quarter, compared to the consensus estimate of $200.32 million. The firm’s revenue for the quarter was up 14.8% on a year-over-year basis. analysts predict that Cantel Medical Corp. will post 2.34 earnings per share for the current year.
The company also recently declared a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Wednesday, January 17th will be issued a $0.085 dividend. This represents a yield of 0.17%. This is an increase from Cantel Medical Corp.’s previous Semi-Annual dividend of $0.07. The ex-dividend date is Tuesday, January 16th. Cantel Medical Corp.’s dividend payout ratio (DPR) is presently 8.19%.
In other Cantel Medical Corp. news, Director Mark N. Diker sold 7,000 shares of the firm’s stock in a transaction on Tuesday, October 3rd. The shares were sold at an average price of $98.90, for a total value of $692,300.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director George L. Fotiades sold 6,000 shares of the firm’s stock in a transaction on Friday, October 13th. The shares were sold at an average price of $95.23, for a total transaction of $571,380.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 36,368 shares of company stock valued at $3,576,028. Insiders own 14.90% of the company’s stock.
Several research analysts recently commented on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical Corp. in a report on Friday, September 1st. Zacks Investment Research downgraded shares of Cantel Medical Corp. from a “buy” rating to a “sell” rating in a report on Wednesday, August 2nd. Finally, Sidoti raised shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective for the company in a report on Wednesday, August 2nd. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Cantel Medical Corp. has an average rating of “Hold” and an average price target of $91.67.
WARNING: “Cantel Medical Corp. (CMD) Shares Sold by Gamco Investors INC. ET AL” was posted by Daily Political and is the property of of Daily Political. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.dailypolitical.com/2017/11/12/cantel-medical-corp-cmd-shares-sold-by-gamco-investors-inc-et-al.html.
About Cantel Medical Corp.
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.